PUBLICATIONS - Medical Devices - Obtaining FDA Market Clearance:
This article was originally published in Clinica
Executive Summary
Medical Devices: Obtaining FDA Market Clearance is a comprehensive reference on the US regulatory clearance process by Jonathan Kahan, a partner at lawyers Hogan & Hartson. Drawing on the experience of the firm's medical device practices group, the book contains detailed analyses of key statutory and regulatory device reforms of the 1990s. Priced at $275 (plus shipping and handling), it is available from Parexel International, 195 West Street, Waltham, MA 02154, US. Tel: +1 (617) 487 9900. Fax: +1 (617) 466 8497; or Jonathan Kahan, Hogan & Hartson, Columbia Square, 555 Thirteenth Street, NW, Washington, DC 20004-1109, US. Tel: +1 (202) 637 5600. Fax: +1 (202) 637 5910.
You may also be interested in...
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.
Dr Reddy’s Knocked Back On Rituximab In US
Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.
Sandoz And Samsung Celebrate Stelara Rival’s EU Approval
Sandoz and Samsung Bioepis have received final European Commission approval for their partnered Pyzchiva biosimilar rival to Stelara. But with European competition on ustekinumab due to kick off in just a matter of months, further applicants are also waiting in the wings.